;
PT. Meiji Indonesian Pharmaceutical Industries
About Us

Company History

2017

2017

Again we launched a new product with the category of skin care, namely Sakura Collagen and also products with category PKRT (Household Health Supplies), namely Rubysta

2016

2016

As a form of action to continue to pursue and create a "new value", this year we launched a new product called Babydex-A, which is a product for babies.

In addition, thanks to the great contribution to the business development of the Meiji Group, we are again awarded by Meiji Seika Pharma Co., Ltd., our parent company in Japan.

 

2014

2014

In this year, exactly on May 13, Meiji celebrated its 40th birthday. Birthday celebration of PT. Meiji Indonesia was held in Surabaya in October.

2013

2013

In mid 2013 we established the Lyophilized project that produces Lyophilized injection (sterile). This new facility has even widely spanned our penetration of specific medicine demanded by the global market.

2011

2011

In 2011 we successfully built up the production facilities for Active Pharmaceutical Ingredients (API) – the biggest one in the region. In its first delivery of the production. It is all meant to fullfill our demand of raw materials of antibiotics that we formulate in our own formulation facilities for export purposes. In 2013 we successfully launched our first batch of raw materials for foreign market after a series of examination, improvement and verifications.

2009

2009

With a great pride, we received an award from our Headquarters, Meiji Japan, first in 2009 for the success of obtaining the higest business performance among Meiji Group globally. This was repeteadly happening in 2010 and 2013 as a reward of the higer achiever among the group.

2001

2001

...and Beta-Lactam 3 factory in 2001.

1997

1997

During this period, we were awarded the GMP (Good Manufacturing Practices) certification for all product categories by the Indonesian Authority – BPOM (the National Agency of Drug and Food Control) in 1994, for which its re-evaluation according the the assesment result were later done in 2006 by the Indonesian Authority – BPOM. Furthermore, we obtained admittance of international quality by the Japanese Regulatory Authority in 2007.

As dynamic enterprise, we spread our wings of expansion through the establishment of Beta-Lactam 2 factory in 1997.

1994

1994

Furthermore, Meiji Seika Kaisha (currently Meiji Seika Pharma Co., Ltd.) Japan gave us trust to produce raw materials of Kanamycin from 1983 – 1991, followed by Ampicillin from 1991 – 1998.

1982

1982

In compliance with the GMP regulation, Beta-Lactam and non Beta-Lactam productions had to operate under seperate buildings, and hence initiated the establishments of Beta-Lactam 1 plant in 1982.

1974

1974

It was the year of 1974 when the history began...

A plain Beta-Lactam and Non Beta-Lactam facilities located in Bangil was the early origin of our present enterprise, built on the land now reachin the size of nearly 103.000 m2.